People with certain forms of early-onset Parkinson's disease could potentially benefit from taking a medication used to treat certain forms of cancer.
Highlights
- Parkinson's disease is a disabling disorder for which no cure is yet available.
- Folinic acid, which is used in medications to treat bowel cancer, can also protect neurons associated with Parkinson's disease.
- Folinic acid which is used for applications in the clinic as an adjuvant during chemotherapy and can be administered orally.
Previous research by the team has shown that folic acid protects neurons in models of Parkinson's disease. Folinic acid is related to folic acid but is metabolically more active. In contrast to folic acid, folinic acid taken orally can penetrate into the human brain.
"With this in mind, it seems worthwhile to further test the supplementation of folinic acid in clinical trials with human participants as a potential preventative or palliative therapeutic for PD and to expand the repertoire of treatment options."
The researchers studied fruit flies with faulty mitochondria caused by a mutation that mimics Parkinson's disease in humans. Lab experiments, like this, allow us to draw conclusions about the effect of folinic acid on neurons in fruit flies.
Facts on Parkinson’s Disease
- Parkinson’s is the second most common neurodegenerative disease.
- Worldwide, 6.3 million people live with the disease.
- Men are 1.5 times more likely to develop the disease than women.
- More than 23,000 die every year due to Parkinson’s.
- There is no cure for the disease but treatments help control the symptoms.
- Dr Miguel Martins et al., Bowel cancer medication could help combat early-onset Parkinson's disease, Science Matters (2017) https://sciencematters.io/articles/201702000009.
Source-Medindia